TP53 mutant AML can certainly reflect loss of canonical p53 apoptotic function given that it cannot transactivate pro-apoptotic targets like PUMA, NOXA, and BAX [49,173]. This evidence concerns the gene PMAIP1 and acute myeloid leukemia.